Drugs / Metformin≥1000mg
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05226897 Background | Jul 2021 → Oct 2022 | type 2 diabetes mellitus | Yooyoung Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Metformin≥1000mg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05226897 ↗ |